UCSD Cancer Center Training Program in Drug Development

加州大学圣地亚哥分校癌症中心药物开发培训项目

• 批准号: 7446128
• 负责人: STEPHEN B HOWELL
• 金额: $ 43.64万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN DIEGO
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-07-01 至 2011-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7446128
• 关键词: Cancer Center; Training Programs; drug development

DESCRIPTION (provided by applicant): This is an application for a new two-year postdoctoral training program in cancer research and more specifically in the development of new cancer agents, at the Rebecca and John Moores UCSD Cancer Center, an NCI designated comprehensive cancer center. The 16 faculty members come from the departments of Medicine, Pathology, Surgery, and Pharmacology within the medical school and the Skaggs UCSD School of Pharmacy and Pharmaceutical Sciences. Each faculty mentor is a participating member of the Cancer Center, having peer reviewed cancer or cancer-related research funding. This program is well integrated into the other cancer related activities of the Caner Center and of UCSD. The goal is to recruit and maintain 8 MD and PhD scientists in this two year program for careers in academic cancer research, with an emphasis on translational research targeted at developmental therapeutics. Trainees will be required to take courses through the medical school managed and NIH funded CREST program; a lecture series coordinated by this training program, Cancer Center and departmental seminars, a journal club for the trainees, and regularly scheduled conferences to expand their cancer research training and perspectives. All of the participating faculty are conducting translational research and have been selected because of their interest in new cancer therapeutics. This program will employ related NCI grant projects including a U56 planning grant for a cancer center/minority institution partnership program in cancer disparities, as well as a pending U54 grant application for an Academic Public, Private Partnership Program (AP4). It will also employ the recently opened Moores Cancer Center building, a 270,000 sf state of the art multi-use structure combining clinical care with basic and prevention research. Methods are in place to ensure that all trainees are properly instructed in the principles of responsible conduct of research and scientific integrity. MD fellows who are interested in academic research related to cancer, and committed to at least two years of research training will be recruited from the Hematology/Oncology, Surgery and Radiology fellowship programs here at UCSD as well as nationwide. PhD applicants come to us from within UCSD and from other research universities with strong backgrounds in biology, biochemistry, chemistry and molecular or cellular biology, and choose to develop their skills related to developing new cancer therapeutics. Special efforts will be made through our partnership grant and other vehicles to recruit and retain exceptional minority and women candidates to the program.

描述（由申请人提供）：这是在丽贝卡（Rebecca）和NCI指定综合癌症中心的丽贝卡（Rebecca）和约翰·摩尔（John Moores）UCSD癌症中心（Rebecca）和约翰·摩尔（John Moores）UCSD癌症中心的癌症研究新两年培训计划的申请。 16名教职员工来自医学院和Skaggs UCSD药学和药学科学学院内的医学，病理，手术和药理学系。每位教师导师都是癌症中心的参与成员，同伴审查了癌症或与癌症相关的研究资金。该程序已很好地整合到Caner Center和UCSD的其他相关活动中。目的是在这项为期两年的学术癌症研究计划中招募和维护8个MD和博士学位科学家，重点是针对发育疗法的转化研究。学员将被要求通过医学院管理和NIH资助的Crest计划参加课程；由该培训计划，癌症中心和部门研讨会，学员的期刊俱乐部以及定期安排的会议，以扩大其癌症研究培训和观点的定期会议。所有参与的教师都在进行转化研究，并因其对新的癌症治疗剂的兴趣而被选中。该计划将采用相关的NCI赠款项目，包括癌症差异的癌症中心/少数民族机构合作伙伴计划的U56计划赠款，以及未决的U54赠款申请，用于学术公共公共，私人合伙计划（AP4）。它还将采用最近开放的摩尔癌中心大楼，这是一个270,000平方英尺的最先进的多用途结构，将临床护理与基本和预防研究相结合。采用方法来确保所有受训者都以负责任的研究和科学完整性的原则进行适当指导。 对与癌症有关的学术研究感兴趣的医学博士研究员，并致力于至少两年的研究培训，将从UCSD以及全国范围内的血液学/肿瘤学，手术和放射学奖学金计划中招募。博士学位申请人来自UCSD内部以及其他具有强大生物学，生物化学，化学和分子或细胞生物学背景的研究所的研究，并选择发展与开发新癌症治疗剂有关的技能。将通过我们的合伙赠款和其他车辆进行特殊努力，以招募和保留杰出的少数民族和妇女候选人参加该计划。